We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Feasability Study of Removing the Ovaries and Fallopian Tubes (TG-Adnex)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01566955
Recruitment Status : Completed
First Posted : March 30, 2012
Last Update Posted : May 27, 2015
Sponsor:
Information provided by (Responsible Party):
Dr. med. Amadeus Hornemann, MPH, Heidelberg University

Brief Summary:
The main reason for this trial is to show the feasibility of removing the ovarien and fallopian tubes through the gaster (transgastric adnexectomy). The background for it is to look for more indications of scarless surgery and we will show that the transgastric adnexectomy can be performed in an easy way. It is necessary that there is an indication for removing the ovaries and fallopian tubes and if the patient agree we will do it instead of through the belly through the gaster and maybe with an additional inzision in the vagina. All patients with indication for adnexectomy are potential candidates.

Condition or disease Intervention/treatment
Ovarian Diseases Procedure: transgastric adnexectomy

Detailed Description:
We will show the feasibility for transgastric adnexectomy in 10 patients. Patients for participating in the study suffer of benign adnexal deseases and there is an indication for removing them for diagnostic, prophylactic or therapeutic reasons. A flexible gastric scope is put transgastric into the abdomen, developing an pneumoperitoneum and removing the adnexes with a monopolar knife. The adnexes then are put out of the abdomen either transvaginally after colpotomy or even transgastric. We already performed an appendectomy in 24 patients and were able to show the feasibility in acute infectios situations.

Study Type : Interventional  (Clinical Trial)
Actual Enrollment : 6 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Feasability of Transgastric Adnexectomy
Study Start Date : April 2012
Primary Completion Date : December 2014
Study Completion Date : December 2014

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arm Intervention/treatment
Experimental: transgastric adnexectomy
patients are operated transgastric
Procedure: transgastric adnexectomy
adnexectomy transgastrically with transvaginal support
Other Names:
  • NOTES
  • Pure NOTES



Primary Outcome Measures :
  1. Number of Participants with conversion to laparoscopy or laparotomy [ Time Frame: 12 months ]
    With the trial we want to demonstrate that the transgastric adnexectomy is possible. We will document the number of patients in which we have to change the transgastric to a laparoscopic or laparotomic operation.


Secondary Outcome Measures :
  1. postoperative well being [ Time Frame: 6 weeks and 6 months ]
    Postoperative well being after 6 weeks and after 6 months (standardized questionaire of our hospital)



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Indication for adnexectomy, agreement to take part in the study

Exclusion Criteria:

  • No agreement in the trial; patients younger than 18 years of age

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01566955


Locations
Germany
University Medical Center Mannheim
Mannheim, Baden-Württemberg, Germany, 68135
Sponsors and Collaborators
Heidelberg University
Investigators
Study Chair: Marc Suetterlin, MD; PhD University of Heidelberg, University Medical Center Mannheim Department of Obstetric and Gynaecology

Publications:
Responsible Party: Dr. med. Amadeus Hornemann, MPH, Dr. Amadeus Hornemann, MPH, PhD, Heidelberg University
ClinicalTrials.gov Identifier: NCT01566955     History of Changes
Other Study ID Numbers: UMM-Mannheim
First Posted: March 30, 2012    Key Record Dates
Last Update Posted: May 27, 2015
Last Verified: May 2015

Keywords provided by Dr. med. Amadeus Hornemann, MPH, Heidelberg University:
transgastric
NOTES
Gastrotomy
BRCA 1/2

Additional relevant MeSH terms:
Ovarian Diseases
Adnexal Diseases
Genital Diseases, Female
Gonadal Disorders
Endocrine System Diseases